Diagnostic Accuracy [qlco]    
SERUM [bdsu]    
Patients [podg]    
Cholangiocarcinoma [neop]    
Review, Systematic [inpr]    
Meta-Analysis [inpr]    
Cholangiocarcinoma [neop]    
CCA [cgab]    
Rare [tmco]    
CANCER [neop]    
Extremely [qlco]    
Asia [geoa]    
Numerous [qnco]    
Reported [inpr]    
SERUM [bdsu]    
Plays [dora]    
DIAGNOSIS [fndg]    
CCA [cgab]    
Patients [podg]    
Published [ocac]    
Inconclusive [idcn]    
Meta-Analysis [inpr]    
Review, Systematic [inpr]    
Diagnostic [fndg]    
Performance [inbe]    
CCA [cgab]    
Material [sbst]    
Methods [inpr]    
Searched [acty]    
Databases [inpr]    
Including [ftcn]    
PubMed [inpr]    
Web [mnob]    
Science [ocdi]    
chinese [lang]    
national [popg]    
Knowledge [inpr]    
Infrastructure [clas]    
Databases [inpr]    
Article [inpr]    
Evaluate [hlca]    
Diagnostic Accuracy [qlco]    
SERUM [bdsu]    
CCA [cgab]    
Diagnostic Sensitivity [qnco]    
Specificity [qnco]    
LIKELIHOOD RATIO [qnco]    
Negative [qlco]    
LIKELIHOOD RATIO [qnco]    
Diagnostic [fndg]    
Odds Ratio [qnco]    
summary [inpr]    
Receiver Operating Characteristic [qnco]    
Curve [spco]    
Pooled [sbst]    
Meta [euka]    
DISC [medd]    
Article [inpr]    
MET [dsyn]    
Inclusion Criteria [qlco]    
Including [ftcn]    
Patients [podg]    
control [qlco]    
Pooled [sbst]    
Sensitivity [patf]    
Specificity [qnco]    
LIKELIHOOD RATIO [qnco]    
Negative [qlco]    
LIKELIHOOD RATIO [qnco]    
Diagnostic [fndg]    
Odds Ratio [qnco]    
CI [geoa]    
CI [geoa]    
CI [geoa]    
3 6 [fndg]    
CI [geoa]    
CI [geoa]    
Area [geoa]    
summary [inpr]    
Receiver Operating Characteristic [qnco]    
Curve [spco]    
Subgroup Analysis [resa]    
Based [ftcn]    
Control Type [resa]    
Geographic Location [geoa]    
Sample Size [qnco]    
Revealed [qlco]    
Diagnostic Accuracy [qlco]    
SAME [qlco]    
Control Type [resa]    
Low [qlco]    
Sensitivity [patf]    
EUROPEAN [popg]    
Patients [podg]    
small group [grpa]    
Size [spco]    
Conclusions [idcn]    
SERUM [bdsu]    
Useful [qlco]    
Non-invasive [ftcn]    
Biomarker [clna]    
CCA [cgab]    
Detection [topp]    
Useful [qlco]    
Tool [mnob]    
HIGH RISK [qlco]    
Patients [podg]    
